Scienture Holdings Inc Asset Turnover Ratio (SCNX), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Scienture Holdings Inc   (NASDAQ: SCNX)
 

Scienture Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Scienture Holdings Inc asset turnover ratio, the ability of Scienture Holdings Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.01 in the first quarter (Mar 31 2026), SCNX's balance sheet remain strong.

Within sector Scienture Holdings Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the First Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCNX Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -28.87 % -24.51 % 3.94 % 478.2 % 458.14 %
Y / Y Revenue Change 449.08 % - 809.71 % - -
Asset Turnover Ratio (TTM) 0.01 - 0.01 - 0
SCNX's Total Ranking # # # # #
Seq. Asset Change -4.43 % -20.71 % 0.54 % -6.64 % 1.44 %
Seq. Revenue Change - - - - -80.68 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




SCNX Company Profile • Back to SCNX Efficiency Comparisons • Compare SCNX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Envoy Medical Inc   0.02 $ 0.234  Millions$ 14.115  Millions
Aim Immunotech Inc   0.02 $ 0.094  Millions$ 5.998  Millions
Alumis inc   0.02 $ 8.402  Millions$ 545.617  Millions
Rallybio Corporation  0.01 $ 0.858  Millions$ 58.849  Millions
Entrada Therapeutics Inc   0.01 $ 5.738  Millions$ 393.644  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 18.069  Millions$ 1,253.296  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 2.526  Millions$ 176.533  Millions
Ataibeckley Inc   0.01 $ 3.488  Millions$ 246.656  Millions
Vyne Therapeutics Inc   0.01 $ 0.535  Millions$ 39.294  Millions
Medicinova Inc   0.01 $ 0.597  Millions$ 46.428  Millions
Prime Medicine Inc   0.01 $ 4.034  Millions$ 325.371  Millions
Vivosim Labs Inc   0.01 $ 0.131  Millions$ 10.925  Millions
Rafael Holdings Inc  0.01 $ 1.131  Millions$ 104.893  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 6.915  Millions
Upstream Bio Inc   0.01 $ 3.322  Millions$ 370.886  Millions
Absci Corp  0.01 $ 1.836  Millions$ 216.693  Millions
Cardiff Oncology Inc   0.01 $ 0.525  Millions$ 62.644  Millions
Nakamoto Inc   0.01 $ 3.920  Millions$ 513.420  Millions
Clene Inc   0.01 $ 0.134  Millions$ 21.058  Millions
Cartesian Therapeutics Inc   0.01 $ 1.775  Millions$ 336.593  Millions
Aclarion Inc   0.01 $ 0.078  Millions$ 15.567  Millions
Silence Therapeutics Plc 0.00 $ 0.839  Millions$ 176.821  Millions
Lightwave Logic Inc 0.00 $ 0.243  Millions$ 60.580  Millions
Prokidney Corp 0.00 $ 0.889  Millions$ 338.025  Millions
Pavmed Inc 0.00 $ 0.107  Millions$ 41.548  Millions
IMPACT BIOMEDICAL INC. 0.00 $ 0.039  Millions$ 17.940  Millions
Cardio Diagnostics Holdings Inc 0.00 $ 0.017  Millions$ 9.128  Millions
Crispr Therapeutics Ag 0.00 $ 4.103  Millions$ 2,316.521  Millions
Sharps Technology Inc 0.00 $ 0.397  Millions$ 227.781  Millions
Roivant Sciences Ltd 0.00 $ 8.260  Millions$ 5,257.314  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.